株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の呼吸装置市場の将来展望

United States Respiratory Devices Market Outlook to 2021

発行 GlobalData 商品コード 351357
出版日 ページ情報 英文 171 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
米国の呼吸装置市場の将来展望 United States Respiratory Devices Market Outlook to 2021
出版日: 2015年11月02日 ページ情報: 英文 171 Pages
概要

当レポートでは、米国における呼吸装置 (呼吸器) 市場について分析し、全体的な市場規模の推移や見通し (金額・数量ベース、過去・今後8年間分)、カテゴリー別の詳細動向、主要企業・流通チャネルの市場シェア、主要企業のプロファイルなどについて調査・推計しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの概要
  • 呼吸装置市場の内訳
  • 当レポートの分析対象市場の定義

第3章 米国の呼吸装置市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
    • ネブライザー (噴霧器):市場収益額の実績値 (過去8年間分)
    • 酸素濃縮器:市場収益額の実績値 (過去8年間分)
    • 気道陽圧装置:市場収益額の実績値 (過去8年間分)
    • 人工呼吸器 (ベンチレーター):市場収益額の実績値 (過去8年間分)
    • ネブライザー:市場収益額の予測値 (今後8年間分)
    • 酸素濃縮器:市場収益額の予測値 (今後8年間分)
    • 気道陽圧装置:市場収益額の予測値 (今後8年間分)
    • 人工呼吸器:市場収益額の予測値 (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
    • ネブライザー:市場規模の実績値 (過去8年間分)
    • 酸素濃縮器:市場規模の実績値 (過去8年間分)
    • 気道陽圧装置:市場規模の実績値 (過去8年間分)
    • 人工呼吸器:市場規模の実績値 (過去8年間分)
    • ネブライザー:市場規模の予測値 (過去8年間分)
    • 酸素濃縮器:市場規模の予測値 (過去8年間分)
    • 気道陽圧装置:市場規模の予測値 (過去8年間分)
    • 人工呼吸器:市場規模の予測値 (過去8年間分)
  • 平均価格の動向・予測 (通算15年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第4章 米国の呼吸装置市場:主要企業の概要

  • Philips Respironics, Inc.
  • ResMed Inc.
  • Medtronic plc
  • GE Healthcare
  • Teleflex Incorporated
  • CareFusion Corporation
  • Draegerwerk AG & Co. KGaA
  • Smiths Medical
  • Fisher & Paykel Healthcare Corporation Limited

第5章 呼吸装置装置市場のパイプライン製品

第6章 資本取引環境

  • 企業買収 (1件)
  • 資産取引 (1件)
  • 社債発行 (全2件)
  • 株式発行 (全2件)
  • 事業提携 (全2件)
  • プライベートエクイティ (未公開株取引) (1件)
  • ベンチャーキャピタル (全2件)

第7章 近年の市場動向

  • 企業からの発表 (全12件)
  • 財務報告 (全27件)
  • 政府・公益関連の動き (全4件)
  • その他の重要な動き (全10件)
  • 製品ニュース (全2件)
  • 戦略・事業計画 (全6件)

第8章 付録

図表一覧

目次
Product Code: GDMECC1310DB

GlobalData's new report, "United States Respiratory Devices Market Outlook to 2021", provides key market data on the United States Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Positive Airway Pressure Devices, Reusable Resuscitators and Oxygen Conservers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Respiratory Devices market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Positive Airway Pressure Devices, Reusable Resuscitators and Oxygen Conservers.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Respiratory Devices market.
  • Global corporate-level profiles of key companies operating within the United States Respiratory Devices market.
  • Key players covered include Philips Respironics, Inc., Medtronic plc, ResMed Inc., GE Healthcare, Draegerwerk AG & Co. KGaA, Teleflex Incorporated, CareFusion Corporation and others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Respiratory Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Respiratory Devices Market, United States

  • 3.1. Respiratory Devices Market, United States, Revenue ($m), 2007-2014
  • 3.2. Respiratory Devices Market, United States, Revenue ($m), 2014-2021
    • 3.2.1. Nebulizers Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Oxygen Concentrators Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Ventilators Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.5. Nebulizers Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.6. Oxygen Concentrators Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.7. Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.8. Ventilators Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.3. Respiratory Devices Market, United States, Volume (Units), 2007-2014
  • 3.4. Respiratory Devices Market, United States, Volume (Units), 2014-2021
    • 3.4.1. Nebulizers Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Oxygen Concentrators Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.4. Ventilators Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.5. Nebulizers Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.6. Oxygen Concentrators Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.7. Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.8. Ventilators Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.5. Respiratory Devices Market, United States, Average Price ($), 2007-2021
  • 3.6. Respiratory Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Respiratory Devices Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Respiratory Devices Market

  • 4.1. Philips Respironics, Inc.
    • 4.1.1. Company Overview
  • 4.2. ResMed Inc.
    • 4.2.1. Company Overview
  • 4.3. Medtronic plc
    • 4.3.1. Company Overview
  • 4.4. GE Healthcare
    • 4.4.1. Company Overview
  • 4.5. Teleflex Incorporated
    • 4.5.1. Company Overview
  • 4.6. CareFusion Corporation
    • 4.6.1. Company Overview
  • 4.7. Draegerwerk AG & Co. KGaA
    • 4.7.1. Company Overview
  • 4.8. Smiths Medical
    • 4.8.1. Company Overview
  • 4.9. Fisher & Paykel Healthcare Corporation Limited
    • 4.9.1. Company Overview

5. Respiratory Devices Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Aerocare Acquires Matrix Medical
  • 6.2. Asset Transactions
    • 6.2.1. Becton, Dickinson Rumored to Sell Respiratory Devices Business
  • 6.3. Debt Offerings
    • 6.3.1. Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016
    • 6.3.2. Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019
    • 6.3.3. Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024
  • 6.4. Equity Offerings
    • 6.4.1. Teladoc Raises USD180.3 Million in IPO
    • 6.4.2. Sangui Biotech to Raise USD5 Million in Private Placement of Shares
  • 6.5. Partnerships
    • 6.5.1. Capsule Tech Enters into Technology Integration Agreement with Masimo
    • 6.5.2. University of Maryland Enters into Agreement with Breethe
  • 6.6. Private Equity
    • 6.6.1. Formation Capital, Safanad, Court Cavendish and Management Team at HC-One Acquire Meridian Healthcare Group
  • 6.7. Venture Financing
    • 6.7.1. Vapotherm Raises USD20 Million in Series C Financing
    • 6.7.2. Spirometrix Raises USD8.6 Million in Series B Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Sep 03, 2015: Julian L. Cohen Joins Teladoc as General Manager and President of Teladoc Behavioral Health
    • 7.1.2. Aug 06, 2015: R. Scott Greer Joins Inogen Board of Directors
    • 7.1.3. Jun 30, 2015: ProVation MD Tapped by Olympus as Recommended EndoWorks Replacement
    • 7.1.4. Jun 19, 2015: Mal Mixon to Retire from Invacare Board of Directors
    • 7.1.5. May 14, 2015: Invacare Adds Two New Board Members
    • 7.1.6. Apr 09, 2015: ALung Appoints David Motley to its Board of Directors
    • 7.1.7. Jan 22, 2015: Invacare Names Matthew E. Monaghan President and Chief Executive Officer
    • 7.1.8. Dec 22, 2014: Invacare Announces Interim Chairman of the Board of Directors
    • 7.1.9. Dec 18, 2014: Pulmonx Names New Chief Executive Officer
    • 7.1.10. Dec 18, 2014: Industry veteran Terrence W. Bunge joins MGC Diagnostics Board
    • 7.1.11. Nov 17, 2014: Nanomix Appoints Dr. Tom Richards as Senior Advisor
    • 7.1.12. Nov 14, 2014: Mal Mixon to Retire as Executive Chairman of Invacare at Year-End
  • 7.2. Financial Announcements
    • 7.2.1. Oct 22, 2015: Invacare Announces Financial Results for the Third Quarter and Nine Months of 2015
    • 7.2.2. Oct 22, 2015: Utah Medical Products Reports Financial Performance for Third Quarter 2015
    • 7.2.3. Sep 15, 2015: Electromed Reports Higher Fourth Quarter and Full Year Revenues and Profits
    • 7.2.4. Sep 10, 2015: MGC Diagnostics Reports Fiscal 2015 Third Quarter Results
    • 7.2.5. Aug 11, 2015: Inogen Announces Second Quarter 2015 Financial Results
    • 7.2.6. Jul 23, 2015: Utah Medical Products Reports Financial Performance for Second Quarter 2015
    • 7.2.7. Jul 23, 2015: Invacare Announces Financial Results for the Second Quarter and First Six Months of 2015
    • 7.2.8. Jun 30, 2015: SANUWAVE Health Provides an Update on the dermaPACE Clinical Trial
    • 7.2.9. Jun 02, 2015: MGC Diagnostics Reports Fiscal 2015 Second Quarter Results
    • 7.2.10. May 12, 2015: Electromed Reports Higher Third Quarter Revenues and Profits
    • 7.2.11. May 12, 2015: Inogen Announces First Quarter 2015 Financial Results
    • 7.2.12. Apr 27, 2015: Inogen Announces Fourth Quarter and Full Year 2014 Financial Results
    • 7.2.13. Apr 23, 2015: Invacare Announces Financial Results for the First Quarter of 2015
    • 7.2.14. Apr 23, 2015: Utah Medical Products Reports Financial Performance for First Quarter 2015
    • 7.2.15. Apr 16, 2015: Arch Therapeutics' AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study
    • 7.2.16. Apr 07, 2015: Positive Clinical Data for iCAD's Xoft System to be Highlighted at American Brachytherapy Society Annual Meeting
    • 7.2.17. Mar 30, 2015: BRILINTA receives US FDA approval for new administration option
    • 7.2.18. Feb 10, 2015: Electromed Reports Higher Second Quarter Revenues and Profits
    • 7.2.19. Feb 05, 2015: CareFusion Reports Second Quarter Fiscal 2015 Results
    • 7.2.20. Feb 05, 2015: Invacare Announces Financial Results for the Quarter and Year Ended December 31, 2014
    • 7.2.21. Jan 29, 2015: UTMD Reports Financial Performance for Fourth Quarter
    • 7.2.22. Jan 29, 2015: Utah Medical Products Reports Financial Performance for Fourth Quarter and Year 2014
    • 7.2.23. Jan 29, 2015: UTMD Reports Financial Performance for Fourth Quarter and Year 2014
    • 7.2.24. Jan 07, 2015: MGC Diagnostics Reports Fiscal 2014 Fourth Quarter and Full Year Results
    • 7.2.25. Nov 12, 2014: Electromed Reports Higher First Quarter Revenues and Profits
    • 7.2.26. Nov 11, 2014: Inogen Releases Third Quarter 2014 Financial Results
    • 7.2.27. Nov 06, 2014: CareFusion Reports First Quarter Fiscal 2015 Results
  • 7.3. Legal And Regulatory
    • 7.3.1. May 04, 2015: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Inogen
    • 7.3.2. Mar 12, 2015: Bernstein Liebhard Announces That It Is Investigating Claims Against Inogen
    • 7.3.3. Feb 18, 2015: OnCore Manufacturing Receives ISO13485 Certification and IPC J-STD-001 QML/ Qualified Manufacturer List at its Suzhou, China facility
    • 7.3.4. Nov 25, 2014: Nanomix Receives ISO 13485:2003 Certification
  • 7.4. Other Significant Developments
    • 7.4.1. Oct 26, 2015: ZOLL Medical Strongly Supports Changes in AHA 2015 Guidelines
    • 7.4.2. Jun 15, 2015: OxySure and Z-Medica Sign Distribution Agreement
    • 7.4.3. May 17, 2015: NATEL and OnCore Renamed: NEO Tech
    • 7.4.4. Feb 13, 2015: Invacare Declares Quarterly Dividend
    • 7.4.5. Jan 16, 2015: Invacare Announces New Credit Agreement
    • 7.4.6. Dec 23, 2014: ALung Releases its 2014 Year in Review Summary
    • 7.4.7. Dec 09, 2014: CareFusion Receives Zenith Award For Respiratory Product Excellence
    • 7.4.8. Dec 04, 2014: CSL Issues "Our Corporate Responsibility 2014" Report
    • 7.4.9. Nov 21, 2014: Invacare Announces Quarterly Dividend
    • 7.4.10. Nov 04, 2014: Utah Medical Products Increases Quarterly Dividend
  • 7.5. Product News
    • 7.5.1. Jun 25, 2015: Spacelabs Reinvents Medical Telemetry with Release of XTR
    • 7.5.2. Apr 29, 2015: New study shows how babies' lives were saved by 3D printing
  • 7.6. Strategy And Business Planning
    • 7.6.1. Mar 25, 2015: Inogen Announces Full Operation of New Primary Manufacturing Facility
    • 7.6.2. Mar 02, 2015: MES Opens New Warehouse in Houston
    • 7.6.3. Feb 10, 2015: Codonics and CareFusion Expand Partnership
    • 7.6.4. Dec 08, 2014: CareFusion And Kit Check To Help Providers Save Time And Improve Medication Safety From The Pharmacy To The OR
    • 7.6.5. Dec 08, 2014: CareFusion, Medacist Partner To Reduce Drug Diversion
    • 7.6.6. Dec 05, 2014: Inogen Expands Manufacturing Capacity to Accommodate Growth

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Company Share Analysis
    • 8.1.5. Distribution Share Analysis
  • 8.2. GlobalData Consulting
  • 8.3. Contact Us
  • 8.4. Disclaimer

List of Tables

  • Table 1: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Nebulizers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Ventilators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Nebulizers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Ventilators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Respiratory Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Table 12: Respiratory Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 13: Nebulizers Market, United States, Volume (Units), Historic, 2007-2014
  • Table 14: Oxygen Concentrators Market, United States, Volume (Units), Historic, 2007-2014
  • Table 15: Positive Airway Pressure Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Table 16: Ventilators Market, United States, Volume (Units), Historic, 2007-2014
  • Table 17: Nebulizers Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 18: Oxygen Concentrators Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 19: Positive Airway Pressure Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 20: Ventilators Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 21: Respiratory Devices Market, United States, Average Price ($) Historic, 2007-2014
  • Table 22: Respiratory Devices Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 23: Respiratory Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 24: Respiratory Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 25: Respiratory Devices Market Pipeline Products
  • Table 26: Aerocare Acquires Matrix Medical
  • Table 27: Becton, Dickinson Rumored to Sell Respiratory Devices Business
  • Table 28: Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016
  • Table 29: Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019
  • Table 30: Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024
  • Table 31: Teladoc Raises USD180.3 Million in IPO
  • Table 32: Sangui Biotech to Raise USD5 Million in Private Placement of Shares
  • Table 33: Capsule Tech Enters into Technology Integration Agreement with Masimo
  • Table 34: University of Maryland Enters into Agreement with Breethe
  • Table 35: Formation Capital, Safanad, Court Cavendish and Management Team at HC-One Acquire Meridian Healthcare Group
  • Table 36: Vapotherm Raises USD20 Million in Series C Financing
  • Table 37: Spirometrix Raises USD8.6 Million in Series B Venture Financing

List of Figures

  • Figure 1: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Respiratory Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Nebulizers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Ventilators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Nebulizers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Ventilators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Respiratory Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 12: Respiratory Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 13: Nebulizers Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 14: Oxygen Concentrators Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 15: Positive Airway Pressure Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 16: Ventilators Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 17: Nebulizers Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 18: Oxygen Concentrators Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 19: Positive Airway Pressure Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 20: Ventilators Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 21: Respiratory Devices Market, United States, Company Share (%) 2014
Back to Top